Back to top
more

Stevanato Group (STVN)

(Delayed Data from NYSE)

$25.58 USD

25.58
677,930

+0.46 (1.83%)

Updated Aug 4, 2025 04:00 PM ET

After-Market: $25.56 -0.02 (-0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 246)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

USNA vs. STVN: Which Stock Is the Better Value Option?

by Zacks Equity Research

USNA vs. STVN: Which Stock Is the Better Value Option?

Zacks Equity Research

UTHR vs. STVN: Which Stock Is the Better Value Option?

by Zacks Equity Research

UTHR vs. STVN: Which Stock Is the Better Value Option?

Zacks Equity Research

CPRX vs. STVN: Which Stock Is the Better Value Option?

by Zacks Equity Research

CPRX vs. STVN: Which Stock Is the Better Value Option?

Zacks Equity Research

Stevanato Group (STVN) Q3 Earnings Match Estimates

by Zacks Equity Research

Stevanato (STVN) delivered earnings and revenue surprises of 0% and 1.89%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Xencor (XNCR) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Xencor (XNCR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

USANA Health Sciences (USNA) Q3 Earnings Surpass Estimates

by Zacks Equity Research

USANA Health (USNA) delivered earnings and revenue surprises of 14.29% and 3.95%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

CPRX or STVN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

CPRX vs. STVN: Which Stock Is the Better Value Option?

Zacks Equity Research

CPRX or STVN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

CPRX vs. STVN: Which Stock Is the Better Value Option?

Zacks Equity Research

TAK vs. STVN: Which Stock Is the Better Value Option?

by Zacks Equity Research

TAK vs. STVN: Which Stock Is the Better Value Option?

Zacks Equity Research

SDZNY vs. STVN: Which Stock Is the Better Value Option?

by Zacks Equity Research

SDZNY vs. STVN: Which Stock Is the Better Value Option?

Zacks Equity Research

Implied Volatility Surging for Stevanato Group (STVN) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Stevanato Group (STVN) stock based on the movements in the options market lately.

Zacks Equity Research

Stevanato Group (STVN) Q2 Earnings Match Estimates

by Zacks Equity Research

Stevanato (STVN) delivered earnings and revenue surprises of 0% and 1.43%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Jazz Pharmaceuticals (JAZZ) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Jazz (JAZZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Analysts Estimate Stevanato Group (STVN) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

USNA vs. STVN: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

USNA vs. STVN: Which Stock Is the Better Value Option?

Zacks Equity Research

USNA or STVN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

USNA vs. STVN: Which Stock Is the Better Value Option?

Zacks Equity Research

Fusion Pharmaceuticals Inc. (FUSN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Fusion Pharmaceuticals (FUSN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Stevanato Group (STVN) to Report Q1 Results: What You Should Expect

by Zacks Equity Research

Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

TAK or STVN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

TAK vs. STVN: Which Stock Is the Better Value Option?

Zacks Equity Research

Stevanato Group (STVN) Q3 Earnings Meet Estimates

by Zacks Equity Research

Stevanato (STVN) delivered earnings and revenue surprises of 0% and 3.22%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

TAK vs. STVN: Which Stock Is the Better Value Option?

by Zacks Equity Research

TAK vs. STVN: Which Stock Is the Better Value Option?

Zacks Equity Research

Akebia Therapeutics (AKBA) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

by Zacks Equity Research

Akebia Therapeutics (AKBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Stevanato Group (STVN) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

USNA or STVN: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

USNA vs. STVN: Which Stock Is the Better Value Option?